+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variability in human in vitro and in vivo metabolism of paclitaxel



Variability in human in vitro and in vivo metabolism of paclitaxel



Clinical Pharmacology & Therapeutics 57(2): 193




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034181431

Download citation: RISBibTeXText


Related references

In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. European Journal of Clinical Pharmacology 67(8): 815-824, 2011

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. International Journal of Pharmaceutics 471(1-2): 525-535, 2015

Variability in human cytochrome P450 paclitaxel metabolism. Journal of Pharmacology and Experimental Therapeutics 275(2): 566-575, 1995

In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer ChemoTherapy and Pharmacology 59(4): 537-548, 2006

The metabolism of the 5HT3 antagonists ondansetron, alosetron and GR87442 I: a comparison of in vitro and in vivo metabolism and in vitro enzyme kinetics in rat, dog and human hepatocytes, microsomes and recombinant human enzymes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 37(8): 832-854, 2007

Incorporation of in vitro variability in cytochrome P450 2E1 activity to describe in vivo variability in m-xylene pharmacokinetics in human volunteers. Toxicology Letters (Shannon) 116(Suppl 1): 85, September 1st, 2000

Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clinical Cancer Research 7(4): 1043-1051, 2001

Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 24(2): 143-155, 1994

Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole. American Journal of Clinical Oncology 20(6): 592-599, 1997

Inhibition of paclitaxel metabolism in vitro in human hepatocytes by Ginkgo biloba preparations. Journal of Dietary Supplements 6(2): 104-110, 2013

Variability of the in vitro metabolism of minaprine validation by comparison with in vivo studies. Strauch, G And J -M Husson (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 185 Pharmacologie Clinique: Actualites Et Perspectives Iii; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 185 Clinical Pharmacology: Current Topics And Future Prospects Iii); Fifth National Meeting on Clinical Pharmacology, Giens, France, September 28-30, 1988 Viii+256p Editions Inserm: Paris, France Paper Illus 213-220, 1989

Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. European Journal of Cancer 46(10): 1882-1891, 2010

Alfentanil metabolism in vivo and in vitro Measuring the individual variability in drug disposition. Anesthesiology (Hagerstown) 79(3A): A376, 1993

In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. Journal of Controlled Release 112(3): 312-319, 2006

Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo. Chemico-Biological Interactions 168(1): 30-50, 2006